Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

fibronectin matrix

Home Drugsfibronectin matrix

fibronectin matrix

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

BI-SPECIFIC EXTRACELLULAR MATRIX BINDING PEPTIDES AND METHODS OF USE THEREOF
EP 3921329 A1Applicant: UNIV TARTUPriority: 2019
CN
EP
US
WO
6 publications
Compositions and methods for treatment of angiogenesis in pathological lesions
US 8623373 B2Applicant: ZARDI LUCIANOPriority: 2001
US
5 publications
ANTICANCER COMPOSITION COMPRISING RECOMBINANT ADENOVIRUS EXPRESSING DEGRADATION FACTOR FOR EXTRACELLULAR MATRIX
EP 3552614 A4Applicant: GENEMEDICINE CO LTDPriority: 2016
CN
EP
US
3 publications
IL-1 RECEPTOR ANTAGONIST (IL-1 RA) FUSION PROTEINS BINDING TO EXTRACELLULAR MATRIX
EP 4165074 A1Applicant: UNIV MONASHPriority: 2020
EP
US
WO
3 publications
BIOLOGICALLY ACTIVE COLLAGEN HYBRIDIZING PEPTIDES
EP 4413030 A4Applicant: 3HELIX INCPriority: 2021
CN
EP
WO
3 publications
METHODS FOR CELL EXPANSION, DIFFERENTIATION, AND/OR HARVESTING OF NATURAL KILLER CELLS USING HOLLOW-FIBER MEMBRANES
EP 4581125 A1Applicant: TERUMO BCT INCPriority: 2022
CN
EP
WO
3 publications
VASCULAR PLANT BASED SCAFFOLD AND IN-VITRO METHOD FOR NEURAL STEM CELL CULTURE
EP 4702133 A1Applicant: UNIV OTTAWAPriority: 2023
CN
EP
WO
3 publications
ADENO ASSOCIATED VIRUS (AAV) MEDIATED LYSYL OXIDASE GENE THERAPY FOR KERATOCONUS AND THE CONSTRUCTS THEREOF
EP 4728083 A1Applicant: NARAYANA NETHRALAYA FOUNDPriority: 2023
CN
EP
WO
3 publications
IL-12 IMMUNOCONJUGATE
EP 3834847 A1Applicant: PHILOGEN SPAPriority: 2011
EP
US
3 publications
Silencing of tgf-beta receptor type II expression by sirna
US 2006229266 A1Applicant: KUMAR NALIN MPriority: 2003
US
3 publications

Page 1 of 9